Literature DB >> 19689231

Clinical trajectories and biological features of primary progressive aphasia (PPA).

E J Rogalski1, M M Mesulam.   

Abstract

Primary Progressive Aphasia (PPA) is a neurodegenerative syndrome characterized by a gradual dissolution of language, but relative sparing of other cognitive domains during the initial stages of the disease. Research has led to substantial progress in understanding the clinical characteristics, genetics, and neuropathology of this syndrome. This article reviews the clinical criteria for diagnosing PPA, discusses the utility of defining the mild cognitive impairment (MCI) stage of PPA, and highlights some of the more recent research advances particularly in the area of pathology and genetics.

Entities:  

Mesh:

Year:  2009        PMID: 19689231      PMCID: PMC2863134          DOI: 10.2174/156720509788929264

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  42 in total

1.  Axonal injury within language network in primary progressive aphasia.

Authors:  Marco Catani; Massimo Piccirilli; Antonio Cherubini; Roberto Tarducci; Tiziana Sciarma; Gianni Gobbi; Gianpiero Pelliccioli; Stefania Maria Petrillo; Umberto Senin; Patrizia Mecocci
Journal:  Ann Neurol       Date:  2003-02       Impact factor: 10.422

2.  Paradoxical features of word finding difficulty in primary progressive aphasia.

Authors:  Rik R Vandenberghe; Mathieu Vandenbulcke; Sandra Weintraub; Nancy Johnson; Kathleen Porke; Cynthia K Thompson; Marsel M Mesulam
Journal:  Ann Neurol       Date:  2005-02       Impact factor: 10.422

3.  Effects of alternative communication on the communicative effectiveness of an individual with a progressive language disorder.

Authors:  Cynthia Pattee; Shelley Von Berg; Patrick Ghezzi
Journal:  Int J Rehabil Res       Date:  2006-06       Impact factor: 1.479

4.  Covert processing of words and pictures in nonsemantic variants of primary progressive aphasia.

Authors:  Emily Rogalski; Alfred Rademaker; Marsel Mesulam; Sandra Weintraub
Journal:  Alzheimer Dis Assoc Disord       Date:  2008 Oct-Dec       Impact factor: 2.703

Review 5.  Clinical, neuroimaging, and pathologic features of progressive nonfluent aphasia.

Authors:  R S Turner; L C Kenyon; J Q Trojanowski; N Gonatas; M Grossman
Journal:  Ann Neurol       Date:  1996-02       Impact factor: 10.422

Review 6.  Primary progressive aphasia--differentiation from Alzheimer's disease.

Authors:  M M Mesulam
Journal:  Ann Neurol       Date:  1987-10       Impact factor: 10.422

7.  Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm.

Authors:  L Fratiglioni; M Viitanen; E von Strauss; V Tontodonati; A Herlitz; B Winblad
Journal:  Neurology       Date:  1997-01       Impact factor: 9.910

8.  Slowly progressive aphasia without generalized dementia.

Authors:  M M Mesulam
Journal:  Ann Neurol       Date:  1982-06       Impact factor: 10.422

9.  Progressive aphasia without dementia: two cases with focal spongiform degeneration.

Authors:  H S Kirshner; O Tanridag; L Thurman; W O Whetsell
Journal:  Ann Neurol       Date:  1987-10       Impact factor: 10.422

10.  Clinical and pathological characterization of progressive aphasia.

Authors:  Jonathan A Knibb; John H Xuereb; Karalyn Patterson; John R Hodges
Journal:  Ann Neurol       Date:  2006-01       Impact factor: 10.422

View more
  18 in total

Review 1.  Clinical utility of FDG-PET for the clinical diagnosis in MCI.

Authors:  Javier Arbizu; Cristina Festari; Daniele Altomare; Zuzana Walker; Femke Bouwman; Jasmine Rivolta; Stefania Orini; Henryk Barthel; Federica Agosta; Alexander Drzezga; Peter Nestor; Marina Boccardi; Giovanni Battista Frisoni; Flavio Nobili
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04-27       Impact factor: 9.236

Review 2.  Quantitating severity and progression in primary progressive aphasia.

Authors:  Bradford C Dickerson
Journal:  J Mol Neurosci       Date:  2011-05-15       Impact factor: 3.444

3.  The Reliability of Telepractice Administration of the Western Aphasia Battery-Revised in Persons With Primary Progressive Aphasia.

Authors:  Leela A Rao; Angela C Roberts; Rhiana Schafer; Alfred Rademaker; Erin Blaze; Marissa Esparza; Elizabeth Salley; Christina Coventry; Sandra Weintraub; M-Marsel Mesulam; Emily Rogalski
Journal:  Am J Speech Lang Pathol       Date:  2022-02-17       Impact factor: 4.018

4.  Clinical course of primary progressive aphasia: clinical and FDG-PET patterns.

Authors:  Jordi A Matias-Guiu; María Nieves Cabrera-Martín; Teresa Moreno-Ramos; Rocío García-Ramos; Jesús Porta-Etessam; José Luis Carreras; Jorge Matías-Guiu
Journal:  J Neurol       Date:  2014-12-10       Impact factor: 4.849

5.  Quantitative template for subtyping primary progressive aphasia.

Authors:  Marsel Mesulam; Christina Wieneke; Emily Rogalski; Derin Cobia; Cynthia Thompson; Sandra Weintraub
Journal:  Arch Neurol       Date:  2009-12

6.  Thinking Outside the Stroke: Treating Primary Progressive Aphasia (PPA).

Authors:  Becky Khayum; Christina Wieneke; Emily Rogalski; Jaimie Robinson; Mary O'Hara
Journal:  Perspect Gerontol       Date:  2012-05

7.  Primary progressive aphasia: A dementia of the language network.

Authors:  Marsel Mesulam
Journal:  Dement Neuropsychol       Date:  2013-01-01

8.  Rehabilitation in semantic dementia: Study of effectiveness of lexical reacquisition in three patients.

Authors:  Mirna Lie Hosogi Senaha; Sonia Maria Dozzi Brucki; Ricardo Nitrini
Journal:  Dement Neuropsychol       Date:  2010 Oct-Dec

9.  Clustering Analysis of FDG-PET Imaging in Primary Progressive Aphasia.

Authors:  Jordi A Matias-Guiu; Josefa Díaz-Álvarez; José Luis Ayala; José Luis Risco-Martín; Teresa Moreno-Ramos; Vanesa Pytel; Jorge Matias-Guiu; José Luis Carreras; María Nieves Cabrera-Martín
Journal:  Front Aging Neurosci       Date:  2018-07-31       Impact factor: 5.750

10.  Modified script training for nonfluent/agrammatic primary progressive aphasia with significant hearing loss: A single-case experimental design.

Authors:  Kristin M Schaffer; Lisa Wauters; Karinne Berstis; Stephanie M Grasso; Maya L Henry
Journal:  Neuropsychol Rehabil       Date:  2020-10-07       Impact factor: 2.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.